Levodopa for the Treatment of Parkinson's Disease.

被引：205

作者：

LeWitt, Peter A. ^{[1
,2
]}

机构：

[1] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA

[2] Wayne State Univ, Dept Neurol, Detroit, MI USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 359卷 / 23期

关键词：

D O I：

10.1056/NEJMct0800326

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2468 / 2476

页数：9

共 55 条

[11] Influence of motor symptoms upon the quality of life of patients with Parkinson's disease [J].

Gomez-Esteban, J. C. ;

Zarranz, J. J. ;

Lezcano, E. ;

Tijero, B. ;

Luna, A. ;

Velasco, F. ;

Rouco, I. ;

Garamendi, I. .

EUROPEAN NEUROLOGY, 2007, 57 (03) :161-165

[12] Medicine-taking behavior: Implications of suboptimal compliance in Parkinson's disease [J].

Grosset, KA ;

Reid, JL ;

Grosset, DG .

MOVEMENT DISORDERS, 2005, 20 (11) :1397-1404

[13] Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease [J].

Hashimoto, T ;

Tokuda, T ;

Hanyu, N ;

Tabata, K ;

Yanagisawa, N .

PARKINSONISM & RELATED DISORDERS, 2003, 9 :S25-S30

[14]

Holloway RG, 2005, ARCH NEUROL-CHICAGO, V62, P430

[15]

Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044

[16] Dopamine miracle: From brain homogenate to dopamine replacement [J].

Hornykiewicz, E .

MOVEMENT DISORDERS, 2002, 17 (03) :501-508

[17] A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease [J].

Hughes, TA ;

Ross, HF ;

Musa, S ;

Bhattacherjee, S ;

Nathan, RN ;

Mindham, RHS ;

Spokes, EGS .

NEUROLOGY, 2000, 54 (08) :1596-1602

[18]

Jellinger KA, 2007, J NEURAL TRANSM-SUPP, P91

[19] The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinson's Disease [J].

Khor, Soo-Peang ;

Hsu, Ann .

CURRENT CLINICAL PHARMACOLOGY, 2007, 2 (03) :234-243

[20]

Koller W, 1987, Adv Neurol, V45, P317

← 1 2 3 4 5 6 →